References
- Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn. 2011;31(1):7–15.
- Wright D, Syngelaki A, Bradbury I, et al. First-trimester screening for trisomies 21, 18 and 13 by ultrasound and biochemical testing. Fetal Diagn Ther. 2014;35(2):118–126.
- Matias A, Gomes C, Flack N, et al. Screening for chromosomal abnormalities at 10–14 weeks. The role of ductus venosus blood flow. Ultrasound Obstet Gynecol. 1998;12(6):380–384.
- Hecher K. Assessment of ductus venosus flow during the first and early second trimesters: what can we expect? Ultrasound Obstet Gynecol. 2001;17(4):285–287.
- Bilardo CM, Müller MA, Zikulnig L, et al. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol. 2001;17(4):288–294.
- Favre R, Cherif Y, Kohler M, et al. The role of fetal nuchal translucency and ductus venosus Doppler at 11–14 weeks of gestation in the detection of major congenital heart defects. Ultrasound Obstet Gynecol. 2003;21(3):239–243.
- Borrell A, Gonce A, Martinez JM, et al. First-trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markers. Prenat Diagn. 2005;25(10):901–905.
- Maiz N, Plasencia W, Dagklis T, et al. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness. Ultrasound Obstet Gynecol. 2008;31(3):256–260.
- Maiz N, Kagan KO, Milovanovic Z, et al. Learning curve for Doppler assessment of ductus venosus flow at 11 + 0 to 13 + 6 weeks’ gestation. Ultrasound Obstet Gynecol. 2008;31(5):503–506.
- Maiz N, Valencia C, Emmanuel EE, et al. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11–13 + 6 weeks of gestation. Obstet Gynecol. 2008;112(3):598–605.
- Maiz N, Valencia C, Kagan KO, et al. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol. 2009;33(5):512–517.
- Syngelaki A, Chelemen T, Dagklis T, et al. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11–13 weeks. Prenat Diagn. 2011;31(1):90–102.
- Baez E, Steinhard J, Huber A, et al. Ductus venosus blood flow velocity waveforms as a predictor for fetal outcome in isolated congenital heart disease. Fetal Diagn Ther. 2005;20(5):383–389.
- Maiz N, Wright D, Ferreira AF, et al. A mixture model of ductus venosus pulsatility index in screening for aneuploidies at 11–13 weeks’ gestation. Fetal Diagn Ther. 2012;31(4):221–229.
- Schaefer M, Laurichesse-Delmas H, Ville Y. The effect of nuchal cord on nuchal translucency measurement at 10–14 weeks. Ultrasound Obstet Gynecol. 1998;11(4):271–273.
- Scheier M, Egle D, Himmel I, et al. Impact of nuchal cord on measurement of fetal nuchal translucency thickness. Ultrasound Obstet Gynecol. 2007;30(2):197–200.
- Plasencia W, Lopez P, Esparza M, et al. Influence of nuchal cord on ductus venosus assessment at 11 to 13 + 6 weeks’ gestation. Ultrasound Obstet Gynecol. 2010;35(3):263–266.